Stephen P. Carey

SVP & CFO · ANI Pharmaceuticals

Stephen P. Carey (SVP & CFO) filed 8 Form 4 reports in the trailing twelve months (0 purchases, 8 sales), most often in ANI Pharmaceuticals, Inc. (ANIP). The largest single filing was $552K of ANIP (7,312 sh across 2 lots, as filed), executed Mar 5. Data as of Nov 8 2026.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 8 sells

Median delay

–

measured on stock purchases

Volume, ttmiDollar value disclosed in the trailing twelve months

$2.2M

shares × price, as filed

Last traded

Oct 29

Filed Oct 30

Median ADV $26.1M across their filed names

Open performance→

Volume by month

Buys $0 Sells $6.9M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 8 filings

Sector per market data · by filing · past 12 months

Most traded names

ANIP

ANI Pharmaceuticals, Inc. ANIP · 0 buys · 10 sells 10 filings

Recent filings

ANIPSALE ANI Pharmaceuticals, Inc. View filing → $208K
2,850 sh × $72.87
Exec Oct 29
Filed Oct 30 · 4:36 PM ET ANIPSALE ANI Pharmaceuticals, Inc. View filing → $208K
2,850 sh × $73.00
Exec Sep 29
Filed Sep 30 · 4:52 PM ET ANIPSALE ANI Pharmaceuticals, Inc. View filing → $207K
2,850 sh × $72.80
Exec Aug 31
Filed Sep 1 · 6:18 PM ET ANIPSALE ANI Pharmaceuticals, Inc. View filing → $232K
2,850 sh × $81.36
Exec Jul 29
Filed Jul 30 · 4:02 PM ET ANIPSALE ANI Pharmaceuticals, Inc. View filing → $285K
3,313 sh × $86.00
Exec Jul 2
Filed Jul 6 · 9:40 PM ET ANIPSALE ANI Pharmaceuticals, Inc. View filing → $240K
2,850 sh × $84.12
Exec Jun 29
Filed Jun 30 · 5:30 PM ET ANIPSALE ANI Pharmaceuticals, Inc. View filing → $265K
3,312 sh × $80.00
Exec Jun 5
Filed Jun 9 · 5:30 PM ET ANIPSALE ANI Pharmaceuticals, Inc. View filing → $552K
7,312 sh across 2 lots
Exec Mar 5
Filed Mar 5 · 5:30 PM ET More filings →